Online citations, reference lists, and bibliographies.
← Back to Search

Intensity‐modulated Radiation Therapy Use In The U.S., 2004

L. Mell, A. K. Mehrotra, A. Mundt
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Intensity‐modulated radiation therapy (IMRT) is a novel approach to the planning and delivery of radiation therapy. The prevalence of IMRT use among radiation oncologists in the U.S. appears to be increasing, despite limited data evaluating its risks and benefits.
This paper references
10.1016/J.IJROBP.2003.11.037
Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
L. Hong (2004)
10.1016/S0360-3016(00)00585-X
Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma.
P. Xia (2000)
10.1016/S0360-3016(99)00550-7
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
L. Dawson (2000)
10.1016/S0360-3016(03)00521-2
Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
A. Lujan (2003)
10.1016/J.IJROBP.2004.06.052
Intensity modulated radiation therapy (IMRT) is a cost-effective treatment for intermediate risk prostate cancer
A. Konski (2004)
10.1002/cncr.11489
A survey of intensity‐modulated radiation therapy use in the United States
L. Mell (2003)
10.1016/J.IJROBP.2004.07.134
Does the dose protraction inherent to IMRT decreases tumor cell killing in vitro
S. Chmura (2004)
Billing and reimbursement issues
C Szerlag
10.1016/S0360-3016(02)03864-6
Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy.
S. Milker-Zabel (2003)
10.1016/J.IJROBP.2004.07.106
Outcome of endometrial cancer patients treated with adjuvant intensity modulated pelvic radiation therapy
B. Knab (2004)
Does the dose protraction inherent to IMRT decrease tumor cell killing in vitro [abstract]
SJ Chmura (2004)
10.1016/S0360-3016(03)01508-6
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
T. Lu (2004)
10.1016/S0360-3016(03)00325-0
Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
A. Mundt (2003)
10.1016/S0360-3016(02)03809-9
Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience.
A. Pirzkall (2003)
10.1038/SCIENTIFICAMERICAN0901-19
Cancer in the crosshairs.
D. Martindale (2001)
10.1016/S0360-3016(02)04150-0
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
10.1002/cncr.20359
Intensity‐modulated radiotherapy and the Internet
D. Schomas (2004)
10.1016/J.IJROBP.2004.06.055
Resident education in intensity modulated radiation therapy (IMRT)
R. Malik (2004)
10.1016/s0360-3016(01)01749-7
Intensity-modulated radiotherapy: current status and issues of interest.
Jedediah S. Purdy (2001)
10.1016/S0360-3016(01)02641-4
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
Eugene Huang (2002)
10.1016/J.IJROBP.2004.06.167
Adjuvant intensity modulated pelvic radiation therapy in gynecologic malignancies: Survey of the gynecologic IMRT working group
L. Mell (2004)
10.1016/J.IJROBP.2004.06.054
Intensity modulated radiation therapy and the internet: Evaluation of the content and quality of patient-oriented information
D. Schomas (2004)
10.1016/S0360-3016(02)02823-7
Intensity-modulated radiation therapy (IMRT) for meningioma.
N. Uy (2002)
10.1016/S0360-3016(00)80393-4
Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience.
L. Kestin (2000)
10.1016/J.IJROBP.2003.09.086
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
H. Murshed (2004)
10.1259/BJR.75.890.750151
Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.
C. Nutting (2002)
10.1177/096228029600500302
Handling missing data in survey research
J. Brick (1996)
Intensity Modulated Radiation Therapy: A Clinical Perspective
A. Mundt (2005)
10.1016/S0360-3016(00)00771-9
Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
J. Roeske (2000)
10.1016/S0167-8140(01)00449-2
Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.
K. Chao (2001)
10.1016/S0360-3016(02)03746-X
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy.
F. Vicini (2002)
10.1016/S0360-3016(02)02836-5
Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
P. Kupelian (2002)
10.1016/J.IJROBP.2004.03.035
IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
R. Ahmed (2004)
10.1016/S0360-3016(02)02857-2
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.
M. Zelefsky (2002)
10.1016/S0360-3016(02)03801-4
Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
Clark J Brixey (2002)
10.1016/S0360-3016(02)03940-8
Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.
K. Chao (2003)
10.1016/S0360-3016(01)01512-7
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
A. Eisbruch (2001)
10.1016/S1078-1439(03)00091-7
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.
M. Zelefsky (2002)
10.1016/J.IJROBP.2003.09.085
Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
H. Liu (2004)
10.1016/S0360-3016(03)00073-7
Radiation-induced second cancers: the impact of 3D-CRT and IMRT.
E. Hall (2003)
Intensity modulated radiation therapy (IMRT) is a cost effective treatment for intermediate risk prostate cancer [abstract
AA Konski (2004)
10.1016/J.RADONC.2003.09.011
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.
V. Grégoire (2003)
10.1016/J.IJROBP.2003.11.003
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
M. Milano (2004)
10.1016/J.IJROBP.2003.09.077
Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions.
D. Gierga (2004)



This paper is referenced by
10.1002/cncr.27578
Impact of diagnosis and treatment of clinically localized prostate cancer on health‐related quality of life for older Americans
B. Reeve (2012)
10.1016/j.eururo.2016.03.033
Concurrent Androgen Deprivation with Radiotherapy: A Cautionary Tale of "Do As I Say, Not As I Do"?
J. Tosoian (2016)
10.1016/j.ijrobp.2012.05.002
A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases.
D. Hodgson (2013)
10.1016/j.currproblcancer.2010.04.004
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
H. Quon (2010)
10.1016/j.ygyno.2014.12.039
Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
L. Chen (2015)
10.3346/jkms.2018.33.e67
A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy
C. H. Rim (2018)
10.1007/s13246-014-0258-9
Evaluation of MegaVoltage Cone Beam CT image quality with an unmodified Elekta Precise Linac and EPID: a feasibility study
T. Markwell (2014)
10.1097/COC.0b013e3182438d92
Utilization of Proton Therapy: Evidence-based, Market-driven, or Something In-between?
T. Dvorák (2013)
10.1016/j.ygyno.2007.10.026
Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
S. Beriwal (2008)
A Generalized Strategy for 3 D Dose Verification of IMRT / VMAT Using EPID-measured Transit Images
A. Ding (2016)
The benefit of automatic segmentation of intracranial organs at risk for radiation therapy: A multi-rater behavioral investigation
M. Deeley (2013)
10.4172/2155-9619.1000304
Radiotherapy Dose Escalation with Concurrent Chemotherapy ImprovesOutcome in Locally Advanced Cervix Carcinoma
Hegazy Mw (2016)
10.1186/1748-717X-6-11
International Conference on Advances in Radiation Oncology (ICARO): Outcomes of an IAEA Meeting
E. Salminen (2011)
10.3109/9780849387821-10
Evaluation of Treatment-Related Toxicity and Clinical Outcome in Lung Cancer Treated by Image-Guided Radiotherapy and Chemotherapy
Z. Liao (2007)
10.1007/S11912-008-0046-3
A review of intensity-modulated radiation therapy
L. Gaspar (2008)
10.1155/2009/752135
Recent Advances in Image-Guided Radiotherapy for Head and Neck Carcinoma
S. Nath (2009)
10.1002/mp.12985
A ring‐based compensator IMRT system optimized for low‐ and middle‐income countries: Design and treatment planning study
Jonathon Van Schelt (2018)
10.1002/cncr.23521
Targeted therapy in head and neck cancer
C. Langer (2008)
10.1517/17425255.4.10.1341
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine
L. Mell (2008)
10.1002/hed.24447
ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas
J. Beitler (2016)
Mesauring The Effect Of Technological Change In Health Care Cost And Expenditure
K. P. Sharma (2010)
10.14744/ejmo.2019.28670
Dosimetric Comparison of Adjuvant Pelvic Radiotherapy for Endometrial Cancer using Intensity-Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT) and Helical Tomotherapy (HT)
Öztun Temelli (2019)
10.1016/j.jacr.2010.01.024
Evaluation of potential proton therapy utilization in a market-based environment.
T. Dvorák (2010)
10.1016/j.brachy.2018.11.009
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
C. Holschneider (2019)
10.1088/0031-9155/55/11/008
The effect of gantry and collimator angles on leaf limited velocity and position in dynamic multileaf collimator intensity-modulated radiation therapy.
M. Okumura (2010)
10.1016/j.cpet.2012.06.006
Radiation Treatment Planning for Head and Neck Cancer with PET.
C. Woods (2012)
10.1016/J.IJROBP.2007.04.037
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach.
K. Chao (2007)
10.1016/j.tipsro.2020.08.002
International survey; current practice in On-line adaptive radiotherapy (ART) delivered using Magnetic Resonance Image (MRI) guidance☆
H. McNair (2020)
10.1097/COC.0b013e3182467db3
Clinical Practice Patterns of Lung Stereotactic Body Radiation Therapy in the United States: A Secondary Analysis
H. Pan (2013)
10.1093/jjco/hyr096
A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer.
T. Toita (2011)
10.1016/j.ygyno.2012.11.012
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
M. Folkert (2013)
10.1001/jama.2013.6882
Use of advanced treatment technologies among men at low risk of dying from prostate cancer.
B. Jacobs (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar